Chromatography

  • Can CRISPR Combat Muscular Problems?

Can CRISPR Combat Muscular Problems?

Sep 19 2018 Read 731 Times

Muscular dystrophy currently affects roughly 70,000 Brits, with symptoms ranging from weakness and pain to severe paralysis and death. In a move that has the medical industry buzzing, a team of researchers have successfully used CRISPR gene editing technology to reverse muscular dystrophy symptoms in dogs. Eventually, the team hope that it could be used to help people with the muscle-wasting disease, which comes in around 60 different forms.

While it's considered a rare disease, around 100 British boys are born with Duchenne MD every year. The inherited genetic condition sees abnormal genes, also known as mutations, hinder with the natural production of dystrophin, a protein needed to grow and support healthy muscles. Mutations are often grouped in a certain region of the gene and can eventually stop protein production altogether. Symptoms begin as early as age three and can quickly escalate, with degeneration often spreading to the heart and respiratory muscles by the early teens. It's rare for patients to live past their 20s, with heart failure usually a common cause of death.

Gene editing technology used to repair puppy DNA

Working with beagle puppies suffering from muscular dystrophy, scientists used CRISPR/Cas9 to manually repair the genetic mutation that hinders the production of dystrophin and triggers muscle degeneration. The technology is powered by two key molecules that forcibly change sequences by binding a scaffold to the DNA, then using a pre-designed sequence to guide Cas9 to the correct part of the genome. The repairs were done by injecting the puppies with a virus carrying the CRISPR gene-editing machinery, then noting the effect on dystrophin levels. After eight weeks they noted that levels of dystrophin increased in every muscle group.

“It was really gratifying to see the efficiency with which dystrophin was restored after only eight weeks,” says Eric Olson, co-author of the study and molecular biologist at the University of Texas Southwestern Medical Centre in Dallas.

Pioneering a cure for muscular dystrophy diseases

The findings were reported in the journal Science and confirm that the medical sphere could be one step closer to developing a treatment for muscular dystrophy diseases. Even small improvements could dramatically improve the lives of patients, with previous studies suggesting that restoring dystrophin to just 15 percent of the levels seen in healthy humans could significantly relieve muscular dystrophy symptoms.

For an in-depth look at one of the latest medical breakthroughs don't miss 'Column Technology for Achiral SFC Separations', which spotlights supercritical fluid chromatography as a powerful tool for the separation of both chiral [1-3] and Achiral [4, 5] compounds.

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Lab Asia December 2018

December 2018

In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...

View all digital editions

Events

Smart Factory Expo (SFE 2019)

Jan 16 2019 Tokyo, Japan

Arab Health

Jan 28 2019 Dubai International Convention & Exhibition Centre

Nano Tech 2019

Jan 30 2019 Tokyo, Japan

World Congress on Chromatography

Jan 31 2019 Paris, France

SLAS 2019

Feb 02 2019 Washington, DC, USA.

View all events